REPERTOIRE BREADTH OF HUMAN CD4(-CELLS SPECIFIC FOR HIV GP120 AND P66(PRIMARY ANTIGENS) OR FOR PPD AND TETANUS TOXOID (SECONDARY ANTIGENS)() T)

Citation
Gl. Pira et al., REPERTOIRE BREADTH OF HUMAN CD4(-CELLS SPECIFIC FOR HIV GP120 AND P66(PRIMARY ANTIGENS) OR FOR PPD AND TETANUS TOXOID (SECONDARY ANTIGENS)() T), Human immunology, 59(3), 1998, pp. 137-148
Citations number
37
Categorie Soggetti
Immunology
Journal title
ISSN journal
01988859
Volume
59
Issue
3
Year of publication
1998
Pages
137 - 148
Database
ISI
SICI code
0198-8859(1998)59:3<137:RBOHCS>2.0.ZU;2-7
Abstract
Antigen derived peptides bound on MHC class II molecules on presenting cells stimulate specific CD4 lymphocytes that are in a naive state if antigen is given for the first time, or in a memory state if antigen has been previously encountered. In order to compare clonal heterogene ity of the human CD4(+) T helper repertoire in primary vs. recall resp onses, we have generated T cell lines in vitro by repeated stimulation of peripheral lymphocytes with primary or with recall antigens. Clona l heterogeneity was bred in the case of recall response to tetanus tor oid or PPD, with a high frequency of specific precursors (>100 cells/1 0(6) lymphocytes). In contrast, T cell lines responsive to primary ant igens (HIV gp120 or HIV p66) were oligoclonal as defined by TCR V beta gene usage and by spectratyping, and the precursor frequency was low (<2 cells/10(6) lymphocytes). Primary T cell lines generated from bloo d samples drawn at different times from the same donor showed that clo nes with identical TCR CDR3 region coding sequences were expanded, sug gesting that in these individuals a large progeny derived from one sin gle precursor is present, even though a previous encounter with I-he a ntigen was not documented. Assuming an even in viva distribution of su ch cells, the presence of one precursor every 10(6) CD4 lymphocytes (w ithin the CD4 T repertoire that comprises roughly 10(11) CD4 T cells) indicates that approximately 10(5) identical T cells from the same clo nal precursor account for the primary response against the model antig ens we have studied. (C) American Society for Histocompatibility and I mmunogenetics, 1998. Published by Elsevier Science Inc.